로딩 중…
지수 로딩 중…
GC Biopharma Corp.
006280· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩124,700-4.52%
2026-06-19
Price Chart
GC Biopharma Corp.-2.81%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 1.46T KRW |
| Revenue | 2.04T KRW |
| Net Income | -39.24B KRW |
| Total Assets | 2.97T KRW |
| Net Assets | 1.39T KRW |
| Employees | 2,355 |
| Value | |
| P/B | 1.05x |
| P/S | 0.71x |
| EV/EBITDA | 31.25x |
| FCF Yield | 1.86% |
| Profitability | |
| ROE | -2.81% |
| ROA | -1.32% |
| Op. Margin | 3.57% |
| Revenue Growth | 13.49% |
| Earnings Growth | -32.17% |
| Financial Health | |
| Debt Ratio | 113.09% |
| Total Debt | 862.25B KRW |
| FCF | 27.10B KRW |
| Cash | 40.73B KRW |
| Current Ratio | 1.25x |
| Net Debt/EBITDA | 11.27x |
| Dividend | |
| Div. Yield | 1.15% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -2.81% |
| 1M Return | -3.78% |
| From 52W High | -32.15% |
| 1Y MDD | -34.17% |
| Trading | |
| Volume | 60,592 shares |
| Foreign Own. | 22.64% |
| Per Share | |
| EPS | -1,189 KRW |
| BPS | 107,655 KRW |
Company Info
Established in 1969 and headquartered in Yongin-si, Gyeonggi-do, Green Cross is a professional pharmaceutical manufacturer and seller specializing in blood products and vaccine products. Its main businesses include blood products, general products, and vaccine products. The company strengthened its raw plasma procurement capabilities by acquiring US ABO Holdings in 2025 and is entering the global market with ALYGLO's US FDA approval and 2024 launch. Green Cross supplies products to domestic and international markets through its Ochang factory production facilities, aiming to become a global pharmaceutical company focused on key strategic products.